Statins and Vascular dementia: A review

Sotirios Giannopoulos, Aristeidis H. Katsanos, Maria Kosmidou, Georgios Tsivgoulis

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The impact of statin therapy on dementia has been a hot topic of debate over the last decade and still remains highly controversial. Among all causes of dementia, vascular dementia (VaD) is the one type that is more likely to benefit from statins. To date no randomized clinical trials have been published and no systematic review has investigated a possible preventive effect of statins on the VaD subtype. In the present literature review, we tried to identify all available data on the effect of statins specifically in patients with VaD, and to further discuss this possible association. Our literature search highlighted two cross-sectional studies, two prospective cohort studies, and one retrospective cohort study. Two of the studies found a significant positive effect of statin treatment on VaD, depicted by the lower incidence of VaD in statin users, while the others reported non-significant associations. The relatively small numbers of VaD patients and statin users, as well as the presence of confounders and biases, make the interpretation of results extremely difficult. Statins may exert a benefit in the prevention of all-type dementia and VaD, through several mechanisms except for hyperlipidemia reduction. A well-designed randomized clinical trial is the ideal study design to address the effect of statin therapy in VaD and to draw final conclusions.

Original languageEnglish (US)
Pages (from-to)S315-S320
JournalJournal of Alzheimer's Disease
Volume42
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Vascular Dementia
Dementia
Cohort Studies
Randomized Controlled Trials
Hyperlipidemias
Therapeutics
Retrospective Studies
Cross-Sectional Studies
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Statins and Vascular dementia : A review. / Giannopoulos, Sotirios; Katsanos, Aristeidis H.; Kosmidou, Maria; Tsivgoulis, Georgios.

In: Journal of Alzheimer's Disease, Vol. 42, 01.01.2014, p. S315-S320.

Research output: Contribution to journalArticle

Giannopoulos, Sotirios ; Katsanos, Aristeidis H. ; Kosmidou, Maria ; Tsivgoulis, Georgios. / Statins and Vascular dementia : A review. In: Journal of Alzheimer's Disease. 2014 ; Vol. 42. pp. S315-S320.
@article{2b75303b5cfb459abdfbd1ab019b5b56,
title = "Statins and Vascular dementia: A review",
abstract = "The impact of statin therapy on dementia has been a hot topic of debate over the last decade and still remains highly controversial. Among all causes of dementia, vascular dementia (VaD) is the one type that is more likely to benefit from statins. To date no randomized clinical trials have been published and no systematic review has investigated a possible preventive effect of statins on the VaD subtype. In the present literature review, we tried to identify all available data on the effect of statins specifically in patients with VaD, and to further discuss this possible association. Our literature search highlighted two cross-sectional studies, two prospective cohort studies, and one retrospective cohort study. Two of the studies found a significant positive effect of statin treatment on VaD, depicted by the lower incidence of VaD in statin users, while the others reported non-significant associations. The relatively small numbers of VaD patients and statin users, as well as the presence of confounders and biases, make the interpretation of results extremely difficult. Statins may exert a benefit in the prevention of all-type dementia and VaD, through several mechanisms except for hyperlipidemia reduction. A well-designed randomized clinical trial is the ideal study design to address the effect of statin therapy in VaD and to draw final conclusions.",
author = "Sotirios Giannopoulos and Katsanos, {Aristeidis H.} and Maria Kosmidou and Georgios Tsivgoulis",
year = "2014",
month = "1",
day = "1",
doi = "10.3233/JAD-132366",
language = "English (US)",
volume = "42",
pages = "S315--S320",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",

}

TY - JOUR

T1 - Statins and Vascular dementia

T2 - A review

AU - Giannopoulos, Sotirios

AU - Katsanos, Aristeidis H.

AU - Kosmidou, Maria

AU - Tsivgoulis, Georgios

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The impact of statin therapy on dementia has been a hot topic of debate over the last decade and still remains highly controversial. Among all causes of dementia, vascular dementia (VaD) is the one type that is more likely to benefit from statins. To date no randomized clinical trials have been published and no systematic review has investigated a possible preventive effect of statins on the VaD subtype. In the present literature review, we tried to identify all available data on the effect of statins specifically in patients with VaD, and to further discuss this possible association. Our literature search highlighted two cross-sectional studies, two prospective cohort studies, and one retrospective cohort study. Two of the studies found a significant positive effect of statin treatment on VaD, depicted by the lower incidence of VaD in statin users, while the others reported non-significant associations. The relatively small numbers of VaD patients and statin users, as well as the presence of confounders and biases, make the interpretation of results extremely difficult. Statins may exert a benefit in the prevention of all-type dementia and VaD, through several mechanisms except for hyperlipidemia reduction. A well-designed randomized clinical trial is the ideal study design to address the effect of statin therapy in VaD and to draw final conclusions.

AB - The impact of statin therapy on dementia has been a hot topic of debate over the last decade and still remains highly controversial. Among all causes of dementia, vascular dementia (VaD) is the one type that is more likely to benefit from statins. To date no randomized clinical trials have been published and no systematic review has investigated a possible preventive effect of statins on the VaD subtype. In the present literature review, we tried to identify all available data on the effect of statins specifically in patients with VaD, and to further discuss this possible association. Our literature search highlighted two cross-sectional studies, two prospective cohort studies, and one retrospective cohort study. Two of the studies found a significant positive effect of statin treatment on VaD, depicted by the lower incidence of VaD in statin users, while the others reported non-significant associations. The relatively small numbers of VaD patients and statin users, as well as the presence of confounders and biases, make the interpretation of results extremely difficult. Statins may exert a benefit in the prevention of all-type dementia and VaD, through several mechanisms except for hyperlipidemia reduction. A well-designed randomized clinical trial is the ideal study design to address the effect of statin therapy in VaD and to draw final conclusions.

UR - http://www.scopus.com/inward/record.url?scp=84920622055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920622055&partnerID=8YFLogxK

U2 - 10.3233/JAD-132366

DO - 10.3233/JAD-132366

M3 - Article

C2 - 24662103

AN - SCOPUS:84920622055

VL - 42

SP - S315-S320

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

ER -